Terason Announces Agreement with SenoRx, Inc. (SENO) to Provide Its Portable Laptop t3000 Ultrasound System for the Launch of a New SenoSonix(TM) Model
4/16/2009 10:50:30 AM
BURLINGTON, Mass.--(BUSINESS WIRE)--Terason, the market leading producer of high performance Laptop Ultrasound™ imaging systems today announced that it has reached an agreement with SenoRx, Inc. (NASDAQ: SENO) to provide its Terason t3000 ultrasound for the launch of an additional model of the SenoSonix™ System. Like the original SenoSonix, the new model is an integration of SenoRx’s EnCor® breast biopsy system with ultrasound imaging. This new version of the device incorporates a microminiaturization ultrasound technology that combines personal computing power and flexibility designed, developed and marketed by Terason. This versatile ultrasound technology coupled with SenoRx’s proprietary EnCor vacuum-assisted biopsy technology results in an attractive alternative model of the SenoSonix System for customers. The modular design and sophisticated imaging architecture are now available in a reduced footprint with increased portability. The original SenoSonix System received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in October 2007 and CE Mark approval in April 2008.
comments powered by